Piper Jaffray raised its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Myriad Genetics (MYGN) PT Raised to $35 at Leerink Partners, 'Core Business Still Stabilizing But GeneSight Remains Key LT'February 7, 2018 6:04 AM Myriad Genetics (MYGN) PT Raised to $37 at Deutsche BankFebruary 7, 2018 6:03 AM Myriad Genetics (MYGN) Tops Q2 EPS by 7c, Beats on Revenues; 'Raises Financial Guidance for Fiscal Year 2018'February 6, 2018 4:27 PM